Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Hongxin Biology
company
About
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
- 11 - 50
Highlights
Details
- Last Funding Type
- Angel
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Hongxin Biology has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Dec 30, 2022 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 30, 2022 | Angel | — | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Hongxin Biology is funded by 2 investors.
Hongtao Capital
and Nanling Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Angel |
|
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
